Related Experiment Video

Updated: May 11, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Inhibiting cancer metastasis via targeting NAPDH oxidase 4

Biao Zhang1, Zhen Liu, Xun Hu

  • 1Cancer Institute a Key Laboratory for Cancer Prevention & Intervention, National Ministry of Education, China.

Biochemical Pharmacology
|May 22, 2013
PubMed

Insights

Targeting NADPH oxidase 4 (NOX4) with Schisandrin B (Sch B) inhibits cancer metastasis. This study shows NOX4 inhibition reduces breast cancer cell migration and distant spread, offering a new therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer metastasis is a leading cause of cancer mortality.
  • NADPH oxidase 4 (NOX4) and its reactive oxygen species (ROS) production are implicated in cancer metastasis.
  • Transforming growth factor-beta (TGF-β) signaling, a key pathway in metastasis, is linked to NOX4 activity.

Purpose of the Study:

  • To investigate the role of NOX4 in TGF-β-induced breast cancer cell migration and metastasis.
  • To evaluate Schisandrin B (Sch B) as a NOX inhibitor for potential anti-metastasis therapy.

Main Methods:

  • Utilized RNA interference (RNAi) to knockdown NOX4 expression in 4T1 breast cancer cells.
  • Assessed cell migration and ROS production in response to TGF-β and NOX4 modulation.
  • Investigated the inhibitory effects of Schisandrin B (Sch B) on NOX4 activity, ROS production, and cell migration.

Main Results:

  • TGF-β enhanced 4T1 cell migration and ROS production, dependent on NOX4 expression.
  • NOX4 knockdown significantly reduced 4T1 cell migration and attenuated lung and bone metastasis.
  • Schisandrin B (Sch B) inhibited NOX4, suppressed TGF-β-induced ROS production, and decreased cell migration.
  • Sch B treatment attenuated distant metastasis of 4T1 cells to lung and bone.

Conclusions:

  • NOX4 plays a critical role in TGF-β-induced breast cancer cell migration and metastasis.
  • Schisandrin B (Sch B) is a novel NOX inhibitor with potent anti-metastatic properties.
  • Targeting NOX4 pharmacologically presents a promising strategy for inhibiting cancer metastasis.

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...